Aim of the collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization
CureVac receives €400 million upfront and up to an additional €1.05 billion in development, regulatory and sales milestone payments as well as tiered royalties; all previous financial considerations from the prior collaboration agreement replaced
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
Submission based on positive SUPERNOVA Phase III trial data which demonstrated a statistically significant reduction in the incidence of COVID?19 in an immunocompromised patient population
An investigational CYP11A1 Inhibitor, for the treatment of metastatic castration-resistant prostate cancer
Laurus Labs receives EIR from USFDA for API facilities
Signs MoUs with Shri Krishna Ayush University and Dabur India
The company has been entrusted with the responsibility of supplying a wide range of essential oncology drugs
The consultative meet, a first of its kind, will bring together representatives from diverse domains of Traditional Medicine (TM) in India
The company will now explore a buyer for its manufacturing site and exit in due course
Subscribe To Our Newsletter & Stay Updated
